Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Treatment of advanced, recurrent, resistant to previous treatments basal and squamous cell skin carcinomas with a synergistic formulation of interferons. Open, prospective study

Figure 1

Patient with BCC for more than 30 years treated several time with surgery and 5-FU and radiation therapies. At the start IFN combination treatment the patient had a tumor lesion in free edge of his inferior reconstructed eyelid. After one-week treatment, it was observed in the place of tumor an ulcerated necrotic wound. At the end of IFN administration schedule a CR was achieved that prolonged for more than 7 years. Other BCC tumor around the treated lesion also improved.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us